Innovative approaches to understand and treat liver cancers.
Mayo Clinic Hepatobiliary SPORE
This study is exploring new ways to treat liver and bile duct cancers by using cutting-edge science and technology, with a focus on making sure the results help patients like you, while also supporting new researchers in the field.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10935703 on NIH RePORTER |
What this research studies
This research focuses on hepatobiliary cancers, including hepatocellular carcinoma, cholangiocarcinoma, and fibrolamellar carcinoma, using advanced translational science and state-of-the-art methodologies. The project aims to enhance therapeutic responses through innovative immunotherapeutics, computational biology, and chemical genomics. It also emphasizes a patient-centered approach, ensuring that the findings directly benefit those affected by these cancers. The research includes robust support systems for investigators, particularly those from underrepresented groups, to foster new talent in the field.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with hepatobiliary cancers, including hepatocellular carcinoma, cholangiocarcinoma, or fibrolamellar carcinoma.
Not a fit: Patients with liver cancers that are not included in the study, or those with advanced disease not amenable to new therapies, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and outcomes for patients with liver cancers.
How similar studies have performed: Previous research in hepatobiliary cancers has shown promising results with innovative approaches, indicating a strong potential for success in this area.
Where this research is happening
Rochester, United States
- Mayo Clinic Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Mc Niven, Mark a. — Mayo Clinic Rochester
- Study coordinator: Mc Niven, Mark a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.